0.60Open1.10Pre Close51 Volume101 Open Interest78.00Strike Price2.41KTurnover60.17%IV1.41%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type0.2025Delta0.2541Gamma441.31Leverage Ratio-0.7553Theta0.0001Rho89.35Eff Leverage0.0052Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet